Razzo, B., Chakraborty, R., Shaikh, H., Fiannaca, L., Girgis, S., Le, S., Whittington, S., Mellgard, G., Lieberman, D., Bigdeli, A., Roth, J., Grady, C., Waugh, E., Nugent, F., Wolfe, Z., Hadidi, S. A., Schinke, C., Binder, A., Strouse, C., Kapur, S., Susanibar-Adaniya, S., Waxman, A., Vogl, D., Cohen, A., Stadtmauer, E., Hwang, W., Garfall, A. (2025). Interim analysis of LimiTec, a prospective trial of limited-duration teclistamab for relapsed/refractory multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-5814